Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Effect of nicotine 6 mg gum on urges to smoke, a randomized clinical trial.

Hansson A, Rasmussen T, Perfekt R, Hall E, Kraiczi H.

BMC Pharmacol Toxicol. 2019 Nov 21;20(1):69. doi: 10.1186/s40360-019-0368-9.

2.

Efficacy and safety of a nicotine mouth spray for smoking cessation; a randomized, multicenter, controlled study in a naturalistic setting.

Nides M, Danielsson T, Saunders F, Perfekt R, Kapikian R, Solla J, Leischow SJ, Myers A.

Nicotine Tob Res. 2018 Nov 18. doi: 10.1093/ntr/nty246. [Epub ahead of print]

PMID:
30452732
3.

Potassium oxalate mouthrinse reduces dentinal hypersensitivity: A randomized controlled clinical study.

Lynch MC, Perfekt R, McGuire JA, Milleman J, Gallob J, Amini P, Milleman K.

J Am Dent Assoc. 2018 Jul;149(7):608-618. doi: 10.1016/j.adaj.2018.02.027. Epub 2018 May 2.

4.

Comparison of Two Forms of Loperamide-Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical Trial.

Cottrell J, Koenig K, Perfekt R, Hofmann R; Loperamide–Simethicone Acute Diarrhoea Study Team.

Drugs R D. 2015 Dec;15(4):363-73. doi: 10.1007/s40268-015-0111-y.

5.

Nicotine gum or patch treatment for smoking cessation and smoking reduction: a multi-centre study in Chinese physicians.

Xiao D, Zhong N, Bai C, Xiu Q, Xie C, Hu D, Mao Y, Perfekt R, Kruse E, Li Q, Liu JJ, Wang C.

Front Med. 2014 Mar;8(1):84-90. doi: 10.1007/s11684-014-0311-9. Epub 2014 Jan 23.

PMID:
24452549
6.

Effects of nicotine mouth spray on urges to smoke, a randomised clinical trial.

Hansson A, Hajek P, Perfekt R, Kraiczi H.

BMJ Open. 2012 Sep 26;2(5). pii: e001618. doi: 10.1136/bmjopen-2012-001618. Print 2012.

7.

Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial.

Tønnesen P, Lauri H, Perfekt R, Mann K, Batra A.

Eur Respir J. 2012 Sep;40(3):548-54. doi: 10.1183/09031936.00155811. Epub 2012 Feb 9.

8.

Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.

Kraiczi H, Hansson A, Perfekt R.

Nicotine Tob Res. 2011 Dec;13(12):1176-82. doi: 10.1093/ntr/ntr139. Epub 2011 Aug 17.

PMID:
21849415
9.

Women with left frontal glioblastoma have a significantly shorter survival--why?

Salford LG, Nordenström E, Skagerberg G, Möller T, Widegren B, Perfekt R.

Neuro Oncol. 2006 Oct;8(4):290-1. Epub 2006 Aug 31. No abstract available.

10.

Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up.

Nilsson P, Larsson EM, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M.

J Neurol. 2005 Apr;252(4):396-402. Epub 2005 Mar 22.

PMID:
15778816
11.

Late mortality among five-year survivors of cancer in childhood and adolescence.

Möller TR, Garwicz S, Perfekt R, Barlow L, Winther JF, Glattre E, Olafsdottir G, Olsen JH, Ritvanen A, Sankila R.

Acta Oncol. 2004;43(8):711-8.

PMID:
15764215
12.

Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.

Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissén M, Isomaa B, Forsen B, Homström N, Saloranta C, Taskinen MR, Groop L, Tuomi T; Botnia study group.

Diabetes. 2005 Jan;54(1):166-74.

13.

Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study.

Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, Andersson M, Mouridsen HT, Möller T, Storm HH.

Eur J Cancer. 2004 May;40(8):1233-43.

PMID:
15110888
14.

Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus.

Shaat N, Ekelund M, Lernmark A, Ivarsson S, Nilsson A, Perfekt R, Berntorp K, Groop L.

Diabetologia. 2004 May;47(5):878-84. Epub 2004 Apr 17.

PMID:
15095040
15.

[Strongly increasing incidence of adenocarcinoma of the esophagus and gastric cardia].

Walther C, Zilling T, Perfekt R, Möller T.

Lakartidningen. 2004 Jan 15;101(3):180-3. Swedish.

PMID:
14763086
16.

A prospective survey of radiotherapy practice 2001 in Sweden.

Möller TR, Brorsson B, Ceberg J, Frödin JE, Lindholm C, Nylén U, Perfekt R; SBU Survey Group.

Acta Oncol. 2003;42(5-6):387-410.

PMID:
14596502
17.
18.

Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients.

Wahlberg P, Anderson H, Biörklund A, Möller T, Perfekt R.

Oral Oncol. 2002 Oct;38(7):706-13.

PMID:
12167424
19.

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.

Brun E, Kjellén E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Perfekt R, Wennerberg J, Strand SE.

Head Neck. 2002 Feb;24(2):127-35.

PMID:
11891942
20.
21.

Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas.

Brun E, Zätterström U, Kjellén E, Wahlberg P, Willén R, Brun A, Perfekt R, Tennvall J.

Acta Oncol. 2001;40(4):491-6.

PMID:
11504309
22.

Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries.

Möller TR, Garwicz S, Barlow L, Winther JF, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H; Association of the Nordic Cancer Registries; Nordic Society for Pediatric Hematology and Oncology.

J Clin Oncol. 2001 Jul 1;19(13):3173-81.

PMID:
11432883
23.

Kidney cadmium as compared to other markers of cadmium exposure in workers at a secondary metal smelter.

Börjesson J, Gerhardsson L, Schütz A, Perfekt R, Mattsson S, Skerfving S.

Am J Ind Med. 2001 Jan;39(1):19-28.

PMID:
11148012
24.

Synovial sarcoma--identification of favorable and unfavorable histologic types: a Scandinavian sarcoma group study of 104 cases.

Skytting B, Meis-Kindblom JM, Larsson O, Virolainen M, Perfekt R, Akerman M, Kindblom LG.

Acta Orthop Scand. 1999 Dec;70(6):543-54.

PMID:
10665717
25.

Clinical course in synovial sarcoma: a Scandinavian sarcoma group study of 104 patients.

Skytting BT, Bauer HC, Perfekt R, Huuhtanen R, Alvegård TA, Berlin O, Gustafson P, Klepp R, Löfvenberg R, Saeter G, Trovik CS, Wahlström O.

Acta Orthop Scand. 1999 Dec;70(6):536-42.

PMID:
10665716
26.

Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma group register.

Skytting BT, Bauer HC, Perfekt R, Nilsson G, Larsson O.

Br J Cancer. 1999 Aug;80(11):1809-14.

27.

The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlén M, Larsson O.

Cancer Res. 1999 Jul 1;59(13):3180-4.

Supplemental Content

Loading ...
Support Center